Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine Shandong University, 44 West Wenhua Road, Jinan, Shandong, 250012, China.
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine Shandong University, 44 West Wenhua Road, Jinan, Shandong, 250012, China.
Eur J Med Chem. 2024 Jan 5;263:115930. doi: 10.1016/j.ejmech.2023.115930. Epub 2023 Nov 7.
The emergence of multidrug-resistant bacteria and the slow development of new antibacterial agents have led to a growing global health crisis. Here, we identified an antibacterial agent possessing 1-methyl-2,5-diphenylpyridin-1-ium core, MA220607, with a dual-targeting mechanism of action (MOA), which exhibited effective killing activity against both Gram-positive (MIC = 0.062-2 μg/mL) and Gram-negative bacteria (MIC = 0.5-4 μg/mL). Moreover, our study revealed that MA220607 could block the formation of bacterial biofilm, which might be the reason for low frequency of resistance. MOA studies showed that MA220607 not only promoted FtsZ protein polymerization, but also increased the permeability of bacterial membranes and altered their proton gradients. In addition, MA220607 had low hemolytic toxicity and could significantly inhibit the growth of bacteria in mice. Molecular dynamics simulations demonstrated that MA220607 could block the transition from the tense (T) to relaxed (R) state of FtsZ protein, thereby perturbing the stepping mechanism of FtsZ protein. Overall, our findings suggest that integrating the dual mechanisms targeting FtsZ protein and cell membranes of bacteria into a single scaffold represents a promising direction for the development of new antibacterial agents.
多药耐药菌的出现和新抗菌药物的研发缓慢,导致了一场日益严重的全球健康危机。在这里,我们鉴定了一种具有 1-甲基-2,5-二苯基吡啶-1-鎓核心的抗菌剂 MA220607,它具有双重作用机制(MOA),对革兰氏阳性菌(MIC = 0.062-2μg/mL)和革兰氏阴性菌(MIC = 0.5-4μg/mL)均具有有效杀伤活性。此外,我们的研究表明,MA220607 可以阻止细菌生物膜的形成,这可能是其耐药频率较低的原因。MOA 研究表明,MA220607 不仅促进了 FtsZ 蛋白的聚合,还增加了细菌膜的通透性并改变了它们的质子梯度。此外,MA220607 具有较低的溶血毒性,并能显著抑制小鼠体内细菌的生长。分子动力学模拟表明,MA220607 可以阻止 FtsZ 蛋白从紧张(T)态到松弛(R)态的转变,从而扰乱 FtsZ 蛋白的步进机制。总体而言,我们的研究结果表明,将靶向 FtsZ 蛋白和细菌细胞膜的双重机制整合到单个支架中,代表了开发新型抗菌剂的一个有前途的方向。